Convergence of biomaterials and immunology: a technology platform for delayed burst release of vaccines. A large challenge in vaccination, particularly in wildlife such as for the growing problem of Chlamydia in koalas, is to provide the necessary booster shots. This project will develop implants that will be inserted under the skin at the time of the first shot, and will spontaneously burst later to release the booster shot to provide protection.
Modelling human brain development with stem cells and biomaterials. With limited resources to directly study and advance our understanding of human neural development, this
proposal will establish models of 4 key stages. Employing innovative, interdisciplinary approaches, biomaterials will be fabricated to provide structural and chemical support for human stem cells during: (i) neural induction, (ii) specification into neuronal progenitor subpopulations, (iii) neuronal maturation and integration ....Modelling human brain development with stem cells and biomaterials. With limited resources to directly study and advance our understanding of human neural development, this
proposal will establish models of 4 key stages. Employing innovative, interdisciplinary approaches, biomaterials will be fabricated to provide structural and chemical support for human stem cells during: (i) neural induction, (ii) specification into neuronal progenitor subpopulations, (iii) neuronal maturation and integration into complex neural networks as well as, (iv) the organisation of neurons into larger 3-dimensional brain structures, namely folding of the human cortex. Further, biomaterials developed here have commercialisation potential, targeted at standardizing the culturing of human stem cells to defined neural populations.
Read moreRead less
DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING. Tissue engineering of bone is emerging as a viable therapy for treating large defects in load-bearing bone. We wish to develop methods for combining novel heparan sulphate molecules (known to deliver growth factors to cell surfaces and thereby cause changes in bone cell phenotype) with load-bearing, macro-porous, biodegradable mineral/polymer biomaterials. Through the study of release profiles, protein adsorption and cell responses ....DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING. Tissue engineering of bone is emerging as a viable therapy for treating large defects in load-bearing bone. We wish to develop methods for combining novel heparan sulphate molecules (known to deliver growth factors to cell surfaces and thereby cause changes in bone cell phenotype) with load-bearing, macro-porous, biodegradable mineral/polymer biomaterials. Through the study of release profiles, protein adsorption and cell responses to these derivatised biomaterials, a novel approach to bone replacement materials can be developed.Read moreRead less
Intelligent scaffolds and methods for repair of osteochondral defects. Osteoarthritis (OA) produces articulation of bone against bone resulting in extreme pain and disability. Of all musculoskeletal disorders, osteoarthritis has the greatest social and economic implications worldwide. By 2030, it is projected that 9.3% of the adult population will suffer from arthritis, significantly affecting their quality of life and overall productivity. A tissue engineered product capable of repairing osteoc ....Intelligent scaffolds and methods for repair of osteochondral defects. Osteoarthritis (OA) produces articulation of bone against bone resulting in extreme pain and disability. Of all musculoskeletal disorders, osteoarthritis has the greatest social and economic implications worldwide. By 2030, it is projected that 9.3% of the adult population will suffer from arthritis, significantly affecting their quality of life and overall productivity. A tissue engineered product capable of repairing osteochondral defects that does not require revision over time but becomes fully integrated with the host tissue will have significant benefits. It will improve patient activity and quality of life, and significantly reduce current health care costs associated with osteoarthritis sufferers.Read moreRead less
Tissue-like, nonlinearly elastic nanobiomaterials for soft tissue regeneration. The purpose of this project is to advance the discipline of soft tissue engineering and regeneration with novel biomaterials, nanotechnology and novel clinical treatment concepts. The key outcomes include new elastic tissue-like nanobiomaterials, new varieties of medical implants and innovative treatment methodology.
Structural design of third generation biomaterials. This project will design third generation biomaterials for heart valves, cartilage and bones that guide the formation of new tissue whilst being dissolved inside the human body. As a result, it is anticipated that painful and costly revision surgery will become obsolete. Major benefits will be achieved in paediatric health as implants will have the ability to grow with the child.
Formation of bone-like materials for bone repair and regeneration. A successful outcome for this project would lead to the production and application of new bone-like calcium phosphate materials. Enhanced bioactivity of this material would lead to higher but controlled rates of calcium phosphate release. An understanding of the formation process of these materials and the controlled release of calcium phosphates has the potential to slow the development of metabolic diseases such as osteoporosis ....Formation of bone-like materials for bone repair and regeneration. A successful outcome for this project would lead to the production and application of new bone-like calcium phosphate materials. Enhanced bioactivity of this material would lead to higher but controlled rates of calcium phosphate release. An understanding of the formation process of these materials and the controlled release of calcium phosphates has the potential to slow the development of metabolic diseases such as osteoporosis. The WHO reports that osteoporosis is the second largest health care problem world-wide. In 2002, 44 million people in the USA were estimated to be at risk. This and similar figures in Australia and around the world emphasize the urgency of understanding and appropriately combating weak bone degenerative diseases.Read moreRead less
Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO an ....Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO and University of Queensland, as well as with companies involved in the commercialisation of polyurethane based medical devices (Aortech P/L), this group is well placed to continue the research at a more applied level once the early basic stage is complete.Read moreRead less
Advanced Polymer Systems For The Delivery Of Anti-Epileptic Drugs To The CNS
Funder
National Health and Medical Research Council
Funding Amount
$593,375.00
Summary
The use of organic conducting polymers as novel platforms for drug delivery is expected to provide significant improvements in our ability to treat and manage illnesses and trauma. A number of novel drug-loaded platforms with the introduction of a conducting polymer component to enable electrically stimulated release, generated physiologically (by onset of an epileptic seizure) or by a bio-corrosion process (stents) provides innovative drug release systems powered autonomously.
Bilayered and growth factor-loaded composite scaffolds for the guided bi-differentiation of bone marrow stem cells. The project will regenerate bone-cartilage (osteochondral) tissues using scaffolds, growth factors, and stem cells in order to repair osteochondral defects. The project will improve the quality of life for ~1.4 million Australians suffering from joint pain and disability due to damage or disease of cartilage and subchondral bone. The project will promote Australia research strength ....Bilayered and growth factor-loaded composite scaffolds for the guided bi-differentiation of bone marrow stem cells. The project will regenerate bone-cartilage (osteochondral) tissues using scaffolds, growth factors, and stem cells in order to repair osteochondral defects. The project will improve the quality of life for ~1.4 million Australians suffering from joint pain and disability due to damage or disease of cartilage and subchondral bone. The project will promote Australia research strength in biomaterials, tissue engineering, and drug delivery. The project will also create research opportunities for PhD students, who will be equipped with interdisciplinary skills.Read moreRead less